Known Medicine
Known Medicine is a biotech company focused on improving cancer treatment outcomes. They utilize a machine learning-based sensitivity assay combined with 'omics data to identify predictive biomarkers and the most likely responders to new drugs. Their platform allows them to test drug responses in living patient cells in vitro, building a large dataset of patient cancer cells responding to various drugs. The company was founded in 2020 by Andrea Mazzocchi, PhD, and Katie-Rose Skelly, MS, with a mission to find the right treatment for every cancer patient. They have processed hundreds of patient samples and added millions of images to their dataset. They are supported by investors and collaborate with clinical partners and scientific advisors.
Known Medicine
Known Medicine is a biotech company focused on improving cancer treatment outcomes. They utilize a machine learning-based sensitivity assay combined with 'omics data to identify predictive biomarkers and the most likely responders to new drugs. Their platform allows them to test drug responses in living patient cells in vitro, building a large dataset of patient cancer cells responding to various drugs. The company was founded in 2020 by Andrea Mazzocchi, PhD, and Katie-Rose Skelly, MS, with a mission to find the right treatment for every cancer patient. They have processed hundreds of patient samples and added millions of images to their dataset. They are supported by investors and collaborate with clinical partners and scientific advisors.
TL;DR
Founded: 2020
Headquarters: Salt Lake City, Utah
Core tech: Patient-derived 3D organoid models + machine learning image analytics
Notable funding: $7.2M seed round (announced Aug 25, 2021)
Company Overview
Problem Domain
Cancer treatment optimization; predictive biomarkers for therapy response.
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
$7.2M
Participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and angel investors
Investor Signal
“Participated investors include venture firms and accelerators (Caffeinated Capital, Khosla Ventures, Cota Capital, Y Combinator, others)”